1Alton GG,Animal Brucellosis,Editor K.Nielson by CRC Press[J].Printed in the United States 1990,379.
2Schurig GG,Sriranganathan N,Corbel MJ Brucellosis vaccines:past,present and future[J].Vet Microbiol,2002,90 (1-4):479-96.
3Cloeckaert A,Jacques I,Grillo MJ,et al.Development and evaluation as vaccines in mice of Brucella melitensis Rev.1 single and double deletion mutants of the bp26 and omp31 genes coding for antigens of diagnostic significance in ovine brucellosis[J].Vaccine,2004,22 (21 -22):2827-35.
4Ko J,Splitter GA.Molecular host-pathogen interaction in brucellosis:current understanding and future approaches to vaccine development for mice and humans[J].Clin MicrobiolRev,2003,16 (1):65 -78.
6Lai F,Schurig GG,Boyle SM.Electroporation of a suicide plasmid bearing a transposon into Brucella abortus[J].Microb Pathog,1990,9 (5):363-8.
7Middleton R,Hofmeister A.New shuttle vectors for ectopic insertion of genes into Bacillus subtilis[J].Plasmid,2004,51 (3):238-45.
8Ugalde JE,Comerci DJ,Leguizamon MS,et al.Evaluation of Brucella abortus Phosphoglucomutase (pgm) Mutant as a New Live Rough-Phenotype Vaccine[J].Infect Immun,2003,71 (11):6264-9.
9Monreal D,Grillo MJ,Gonzalez D,et al.Characterization of Brucella abortus O-polysaccharide and core lipopolysaccharide mutants and demonstration that a complete core is required for rough vaccines to be efficient against Brucella abortus and Brucella ovis in the mouse model[J].Infect Immun,2003,71 (6):3261 -71.
10Vemulapalli R,He Y,Buccolo LS,et al.Complementation of Brucella abortus RB51 with a functional wboA gene results in O-antigen synthesis and enhanced vaccine efficacy but no change in rough phenotype and attenuation[J].Infect Immun,2000,68 (7):3927 -32.
3Kemner JM,Liang X,Nester EW .The Agrobacterium tume- faciens virulence gene chvE is part of a putative ABC-type sugar transport operon[J].J Bacteriol,1997,179 (7):2452-2458.
4Van Bastelaere E,Lambrecht M,Vermeiren H,et al.Characteri-zation of a sugar-binding protein from Azospirillum brasilense mediating chemotaxis to and uptake of sugars[J].Mol Microbiol,1999,32 (4):703-714.
5DelVecchio VG,Kapatral V,Redkar RJ,et al.The genome sequence of the facultative intracellular pathogen Brucella melitensis[J].Microbiology,2002,99(1):443-448.
6Sieira R,Comerci DJ,Sanchez DO,et al.A homologue of an operon required for DNA transfer in Agrobacterium is required in Brucella abortus for virulence and intracellular multiplication[J].J Bacteriol,2000,182(17):4849-4855.
7Moreno E,Stackebrandt E,Dorsch M ,et al.Brucella abortus 16S rRNA and lipid A reveal a phylogenetic relationship with members of the alpha-2 subdivision of the class Proteobacteria[J].J Bacteriol,1990,172 (7):3569-3576.
9Wood JM.Osmosensing by bacteria:signals and membrane-based sensors[J].Microbiol Mol Biol Rev,1999,63(1) :230-262.
10Rodriguez MC,Froger A,Rolland JP,et al.A functional water channel protein in the pathogenic bacterium Brucella abortus[J].Microbiology,2000,146 (12):3251-3257.
2CloeckaertA, Jacques I, GrilloMJ, et al. Development and evaluation as vaccines in mice of Brucella melitensis Rev. 1 single and double deletion mutants of the bp26 and omp31 genes coding for antigens of diagnostic significance in ovine brucellosis [ J ] . Vaccine, 2004, 22 (21 - 22) : 2827 -2835.
3美J,萨姆布鲁克,等著,黄培堂,等译.分子克隆实验指南,科学出版社,第三版,2008.
4Ugalde JE, Czibener C, Feldman MF, et al. Identification and characterization of the Brucella abortus phosphoglucomutase gene: role of lipopolysaccharide in virulence and intracellular multiplication [ J ] . Infect Immun, 2000, 68 (10) : 5716 -5723.
5Ugalde JE, Comerci DJ, Leguizamon MS, et al. Evaluation of Brucella abortus Phosphoglucomutase (pgm) Mutant as a New Live Rough - Phenotype Vaccine [ J ] . Infect Immun, 2003, 71 ( 11 ) : 6264 6269.
